[L04AA04, rabbit anti-human T-lymphocyte globulin, Estrone may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit).]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estrone.]
[L04AX02, thalidomide, Estrone may increase the thrombogenic activities of Thalidomide.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Estrone.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Estrone.]
[S01BA05, triamcinolone, The serum concentration of Triamcinolone can be increased when it is combined with Estrone.]
[L04AA26, belimumab, Estrone may increase the thrombogenic activities of Belimumab.]
[L01FX04, ipilimumab, Estrone may increase the thrombogenic activities of Ipilimumab.]
[N06AX09, viloxazine, The metabolism of Estrone can be decreased when combined with Viloxazine.]
[L01FX05, brentuximab vedotin, Estrone may increase the thrombogenic activities of Brentuximab vedotin.]
[S01XA15, ascorbic acid, The serum concentration of Ascorbic acid can be decreased when it is combined with Estrone.]
[L04AA34, alemtuzumab, Estrone may increase the thrombogenic activities of Alemtuzumab.]
[L01FA01, rituximab, Estrone may increase the thrombogenic activities of Rituximab.]
[H02AB11, prednylidene, The serum concentration of Prednylidene can be increased when it is combined with Estrone.]
[L01FX02, gemtuzumab ozogamicin, Estrone may increase the thrombogenic activities of Gemtuzumab ozogamicin.]
[L01FD02, pertuzumab, Estrone may increase the thrombogenic activities of Pertuzumab.]
[L02BB04, enzalutamide, The serum concentration of Estrone can be decreased when it is combined with Enzalutamide.]
[H02AA01, aldosterone, The serum concentration of Aldosterone can be increased when it is combined with Estrone.]
[J06BC02, raxibacumab, Estrone may increase the thrombogenic activities of Raxibacumab.]
[G03XC05, ospemifene, The risk or severity of adverse effects can be increased when Estrone is combined with Ospemifene.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Estrone.]
[L01EC02, dabrafenib, The serum concentration of Estrone can be decreased when it is combined with Dabrafenib.]
[S03BA03, betamethasone, The serum concentration of Betamethasone can be increased when it is combined with Estrone.]
[L04AC11, siltuximab, Estrone may increase the thrombogenic activities of Siltuximab.]
[L01FG02, ramucirumab, Estrone may increase the thrombogenic activities of Ramucirumab.]
[L04AA33, vedolizumab, Estrone may increase the thrombogenic activities of Vedolizumab.]
[L01FF02, pembrolizumab, Estrone may increase the thrombogenic activities of Pembrolizumab.]
[A10BJ05, dulaglutide, Estrone may increase the thrombogenic activities of Dulaglutide.]
[L01FX07, blinatumomab, Estrone may increase the thrombogenic activities of Blinatumomab.]
[J05AP09, dasabuvir, The risk or severity of liver enzyme elevations can be increased when Estrone is combined with Dasabuvir.]
[L01FF01, nivolumab, Estrone may increase the thrombogenic activities of Nivolumab.]
[L04AC10, secukinumab, Estrone may increase the thrombogenic activities of Secukinumab.]
[C10AX14, alirocumab, Estrone may increase the thrombogenic activities of Alirocumab.]
[C10AX13, evolocumab, Estrone may increase the thrombogenic activities of Evolocumab.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Estrone.]
[V03AB37, idarucizumab, Estrone may increase the thrombogenic activities of Idarucizumab.]
[A16AB13, asfotase alfa, Estrone may increase the thrombogenic activities of Asfotase alfa.]
[R03DX09, mepolizumab, Estrone may increase the thrombogenic activities of Mepolizumab.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Estrone.]
[L01FC01, daratumumab, Estrone may increase the thrombogenic activities of Daratumumab.]
[L01FE03, necitumumab, Estrone may increase the thrombogenic activities of Necitumumab.]
[L01FX08, elotuzumab, Estrone may increase the thrombogenic activities of Elotuzumab.]
[J06BB02, tetanus immune globulin, Estrone may increase the thrombogenic activities of Tetanus immune globulin, human.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Estrone.]
[L04AC13, ixekizumab, Estrone may increase the thrombogenic activities of Ixekizumab.]
[R03DX08, reslizumab, Estrone may increase the thrombogenic activities of Reslizumab.]
[J06BC04, obiltoxaximab, Estrone may increase the thrombogenic activities of Obiltoxaximab.]
[L01FF05, atezolizumab, Estrone may increase the thrombogenic activities of Atezolizumab.]
[J06BC03, bezlotoxumab, Estrone may increase the thrombogenic activities of Bezlotoxumab.]
[L01FX10, olaratumab, Estrone may increase the thrombogenic activities of Olaratumab.]
[L04AC12, brodalumab, Estrone may increase the thrombogenic activities of Brodalumab.]
[L01FF04, avelumab, Estrone may increase the thrombogenic activities of Avelumab.]
[L04AA36, ocrelizumab, Estrone may increase the thrombogenic activities of Ocrelizumab.]
[D11AH05, dupilumab, Estrone may increase the thrombogenic activities of Dupilumab.]
[L04AC01, daclizumab, Estrone may increase the thrombogenic activities of Daclizumab.]
[L04AB02, infliximab, Estrone may increase the thrombogenic activities of Infliximab.]
[L01FF03, durvalumab, Estrone may increase the thrombogenic activities of Durvalumab.]
[L04AC14, sarilumab, Estrone may increase the thrombogenic activities of Sarilumab.]
[L04AC16, guselkumab, Estrone may increase the thrombogenic activities of Guselkumab.]
[J06BD01, palivizumab, Estrone may increase the thrombogenic activities of Palivizumab.]
[L01FB01, inotuzumab ozogamicin, Estrone may increase the thrombogenic activities of Inotuzumab ozogamicin.]
[L04AC02, basiliximab, Estrone may increase the thrombogenic activities of Basiliximab.]
[R03BA02, budesonide, The serum concentration of Budesonide can be increased when it is combined with Estrone.]
[R03DX10, benralizumab, Estrone may increase the thrombogenic activities of Benralizumab.]
[B02BX06, emicizumab, Estrone may increase the thrombogenic activities of Emicizumab.]
[J05AX23, ibalizumab, Estrone may increase the thrombogenic activities of Ibalizumab.]
[M05BX05, burosumab, Estrone may increase the thrombogenic activities of Burosumab.]
[N02CD01, erenumab, Estrone may increase the thrombogenic activities of Erenumab.]
[L01XX62, ivosidenib, The metabolism of Estrone can be increased when combined with Ivosidenib.]
[L04AC17, tildrakizumab, Estrone may increase the thrombogenic activities of Tildrakizumab.]
[L01FX09, mogamulizumab, Estrone may increase the thrombogenic activities of Mogamulizumab.]
[B06AC05, lanadelumab, Estrone may increase the thrombogenic activities of Lanadelumab.]
[N02CD03, fremanezumab, Estrone may increase the thrombogenic activities of Fremanezumab.]
[L01FF06, cemiplimab, Estrone may increase the thrombogenic activities of Cemiplimab.]
[N02CD02, galcanezumab, Estrone may increase the thrombogenic activities of Galcanezumab.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Estrone.]
[L04AA39, emapalumab, Estrone may increase the thrombogenic activities of Emapalumab.]
[L04AA43, ravulizumab, Estrone may increase the thrombogenic activities of Ravulizumab.]
[B01AX07, caplacizumab, Estrone may increase the thrombogenic activities of Caplacizumab.]
[M05BX06, romosozumab, Estrone may increase the thrombogenic activities of Romosozumab.]
[H02AB14, cloprednol, The serum concentration of Cloprednol can be increased when it is combined with Estrone.]
[H02AB17, cortivazol, The serum concentration of Cortivazol can be increased when it is combined with Estrone.]
[L04AC18, risankizumab, Estrone may increase the thrombogenic activities of Risankizumab.]
[L01FX14, polatuzumab vedotin, Estrone may increase the thrombogenic activities of Polatuzumab vedotin.]
[S01LA06, brolucizumab, Estrone may increase the thrombogenic activities of Brolucizumab.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Estrone.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Estrone.]
[L01FD01, trastuzumab, Estrone may increase the thrombogenic activities of Trastuzumab.]
[L01FD04, trastuzumab deruxtecan, Estrone may increase the thrombogenic activities of Trastuzumab deruxtecan.]
[L01FD03, ado-trastuzumab emtansine, Estrone may increase the thrombogenic activities of Trastuzumab emtansine.]
[N03AX25, cenobamate, The serum concentration of Estrone can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Estrone can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Estrone.]
[N05CM21, lemborexant, The serum concentration of Estrone can be decreased when it is combined with Lemborexant.]
[L01FC02, isatuximab, Estrone may increase the thrombogenic activities of Isatuximab.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Estrone.]
[N02CD05, eptinezumab, Estrone may increase the thrombogenic activities of Eptinezumab.]
[L04AA38, ozanimod, Estrone may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01FX17, sacituzumab govitecan, Estrone may increase the thrombogenic activities of Sacituzumab govitecan.]
[L04AA47, inebilizumab, Estrone may increase the thrombogenic activities of Inebilizumab.]
[L01FX12, tafasitamab, Estrone may increase the thrombogenic activities of Tafasitamab.]
[L01FX15, belantamab mafodotin, Estrone may increase the thrombogenic activities of Belantamab mafodotin.]
[L04AC19, satralizumab, The serum concentration of Estrone can be decreased when it is combined with Satralizumab.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Estrone.]
[J06BD04, ansuvimab, Estrone may increase the thrombogenic activities of Ansuvimab.]
[L01FD06, margetuximab, Estrone may increase the thrombogenic activities of Margetuximab.]
[P03AX07, abametapir, The serum concentration of Estrone can be increased when it is combined with Abametapir.]
[R03BA03, flunisolide, The serum concentration of Flunisolide can be increased when it is combined with Estrone.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Estrone.]
[S01LA08, bevacizumab, Estrone may increase the thrombogenic activities of Bevacizumab.]
[L01FF07, dostarlimab, Estrone may increase the thrombogenic activities of Dostarlimab.]
[L01FX22, loncastuximab tesirine, Estrone may increase the thrombogenic activities of Loncastuximab tesirine.]
[L01FX18, amivantamab, Estrone may increase the thrombogenic activities of Amivantamab.]
[J06BD05, sotrovimab, Estrone may increase the thrombogenic activities of Sotrovimab.]
[N06DX03, aducanumab, Estrone may increase the thrombogenic activities of Aducanumab.]
[H01AC07, somapacitan, The therapeutic efficacy of Somapacitan can be decreased when used in combination with Estrone.]
[L04AA51, anifrolumab, Estrone may increase the thrombogenic activities of Anifrolumab.]
[L01FX23, tisotumab vedotin, Estrone may increase the thrombogenic activities of Tisotumab vedotin.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Estrone.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Estrone.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Estrone.]
[L02BG06, exemestane, The therapeutic efficacy of Exemestane can be decreased when used in combination with Estrone.]
[R03DX11, tezepelumab, Estrone may increase the thrombogenic activities of Tezepelumab.]
[D11AH07, tralokinumab, Estrone may increase the thrombogenic activities of Tralokinumab.]
[L04AA55, sutimlimab, Estrone may increase the thrombogenic activities of Sutimlimab.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Estrone.]
[C01EB24, mavacamten, The serum concentration of Estrone can be decreased when it is combined with Mavacamten.]
[L04AC22, spesolimab, Estrone may increase the thrombogenic activities of Spesolimab.]
[L01FX20, tremelimumab, Estrone may increase the thrombogenic activities of Tremelimumab.]
[L04AA57, ublituximab, Estrone may increase the thrombogenic activities of Ublituximab.]
[L01FE02, panitumumab, Estrone may increase the thrombogenic activities of Panitumumab.]
[H01AC08, somatrogon, The metabolism of Estrone can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, Estrone may increase the thrombogenic activities of Bimekizumab.]
[J06BB04, hepatitis B immune globulin, Estrone may increase the thrombogenic activities of Hepatitis B immune globulin.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Estrone.]
[S01BA03, cortisone, The serum concentration of Cortisone can be increased when it is combined with Estrone.]
[H02AB15, meprednisone, The serum concentration of Meprednisone can be increased when it is combined with Estrone.]
[R03DX05, omalizumab, Estrone may increase the thrombogenic activities of Omalizumab.]
[G03XX01, prasterone, The risk or severity of adverse effects can be increased when Prasterone is combined with Estrone.]
[L01FE01, cetuximab, Estrone may increase the thrombogenic activities of Cetuximab.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be increased when it is combined with Estrone.]
[L04AB04, adalimumab, Estrone may increase the thrombogenic activities of Adalimumab.]
[L04AX04, lenalidomide, Estrone may increase the thrombogenic activities of Lenalidomide.]
[J06BB01, Rho(D) immune globulin, Estrone may increase the thrombogenic activities of Human Rho(D) immune globulin.]
[L04AA23, natalizumab, Estrone may increase the thrombogenic activities of Natalizumab.]
[L04AA21, efalizumab, Estrone may increase the thrombogenic activities of Efalizumab.]
[H01AA01, corticotropin, The serum concentration of Corticotropin can be increased when it is combined with Estrone.]
[H02CA01, trilostane, The serum concentration of Trilostane can be increased when it is combined with Estrone.]
[J06BB03, varicella-zoster immune globulin, Estrone may increase the thrombogenic activities of Human varicella-zoster immune globulin.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Estrone.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, Estrone may increase the thrombogenic activities of Antilymphocyte immunoglobulin (horse).]
[L04AA02, muromonab-CD3, Estrone may increase the thrombogenic activities of Muromonab.]
[H02AA02, fludrocortisone, The serum concentration of Fludrocortisone can be increased when it is combined with Estrone.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Estrone.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Estrone.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Estrone.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Estrone.]
[S02BA01, hydrocortisone, The serum concentration of Hydrocortisone can be increased when it is combined with Estrone.]
[H01AC02, somatrem, The metabolism of Estrone can be increased when combined with Somatrem.]
[L04AA25, eculizumab, Estrone may increase the thrombogenic activities of Eculizumab.]
[S01LA04, ranibizumab, Estrone may increase the thrombogenic activities of Ranibizumab.]
[H01AC01, somatropin, The metabolism of Estrone can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, Estrone may increase the thrombogenic activities of Tocilizumab.]
[H02AB04, methylprednisolone, The serum concentration of Methylprednisolone can be increased when it is combined with Estrone.]
[L04AB05, certolizumab pegol, Estrone may increase the thrombogenic activities of Certolizumab pegol.]
[L04AA52, ofatumumab, Estrone may increase the thrombogenic activities of Ofatumumab.]
[N04BC04, ropinirole, Estrone may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy.]
[H02AB05, paramethasone, The serum concentration of Paramethasone can be increased when it is combined with Estrone.]
[L01FX01, edrecolomab, Estrone may increase the thrombogenic activities of Edrecolomab.]
[L04AB06, golimumab, Estrone may increase the thrombogenic activities of Golimumab.]
[B01AC13, abciximab, Estrone may increase the thrombogenic activities of Abciximab.]
[L04AC05, ustekinumab, Estrone may increase the thrombogenic activities of Ustekinumab.]
[L02BG03, anastrozole, The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrone.]
[L04AC08, canakinumab, Estrone may increase the thrombogenic activities of Canakinumab.]
[J05AE03, ritonavir, The risk or severity of liver enzyme elevations can be increased when Estrone is combined with Ritonavir.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Estrone.]
[S03BA02, prednisolone, The serum concentration of Prednisolone can be increased when it is combined with Estrone.]
[H02AB07, prednisone, The serum concentration of Prednisone can be increased when it is combined with Estrone.]
[L01FA03, obinutuzumab, Estrone may increase the thrombogenic activities of Obinutuzumab.]
[M05BX04, denosumab, Estrone may increase the thrombogenic activities of Denosumab.]
